• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估氟喹诺酮类药物相关的主动脉瘤和主动脉夹层:美国食品药品监督管理局不良事件报告系统公开版本的数据挖掘

Assessing fluoroquinolone-associated aortic aneurysm and dissection: Data mining of the public version of the FDA adverse event reporting system.

作者信息

Meng Long, Huang Jing, Jia Yuntao, Huang Huali, Qiu Feng, Sun Shusen

机构信息

Department of Pharmacy, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Department of Respiratory, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

出版信息

Int J Clin Pract. 2019 May;73(5):e13331. doi: 10.1111/ijcp.13331. Epub 2019 Apr 25.

DOI:10.1111/ijcp.13331
PMID:30809871
Abstract

AIMS

A recent large epidemiological study found fluoroquinolone use is associated with an increased risk of aortic aneurysm or dissection. We aimed to examine fluoroquinolone (ciprofloxacin, levofloxacin and moxifloxacin) associated aortic aneurysm or dissection through data mining of the US Food and Drug Administration Adverse Event Reporting System (FAERS).

METHODS

Reports to the FAERS from 1 January 2004 to 31 December 2016 were analysed. Pharmacovigilance tools were used for quantitative detection of signals that is, drug-associated adverse events, including reporting odds ratio, proportional reporting ratio, information component given by a Bayesian confidence propagation neural network and empirical Bayes geometric mean. Sensitivity analyses that limited the data by gender and adverse event date also showed similar trends.

RESULTS

Based on 3721 adverse event reports, all three fluoroquinolones are associated with aortic aneurysm, and levofloxacin is associated with aortic dissection. The risk of aortic aneurysm is higher than the aortic dissection. Oral administration of fluoroquinolones is more likely to produce these adverse events.

CONCLUSION

The results obtained herein are consistent with clinical observations, suggesting the necessity for further clinical research on aortic aneurysm and dissection associated with fluoroquinolones.

摘要

目的

最近一项大型流行病学研究发现,使用氟喹诺酮类药物会增加患主动脉瘤或主动脉夹层的风险。我们旨在通过挖掘美国食品药品监督管理局不良事件报告系统(FAERS)的数据,研究氟喹诺酮类药物(环丙沙星、左氧氟沙星和莫西沙星)与主动脉瘤或主动脉夹层的相关性。

方法

分析了2004年1月1日至2016年12月31日期间向FAERS提交的报告。使用药物警戒工具对信号进行定量检测,即药物相关不良事件,包括报告比值比、比例报告比、贝叶斯置信传播神经网络给出的信息成分和经验贝叶斯几何均值。按性别和不良事件日期对数据进行限制的敏感性分析也显示出类似趋势。

结果

基于3721份不良事件报告,所有三种氟喹诺酮类药物均与主动脉瘤相关,左氧氟沙星与主动脉夹层相关。主动脉瘤的风险高于主动脉夹层。口服氟喹诺酮类药物更易发生这些不良事件。

结论

本文获得的结果与临床观察结果一致,提示有必要对氟喹诺酮类药物相关的主动脉瘤和主动脉夹层进行进一步临床研究。

相似文献

1
Assessing fluoroquinolone-associated aortic aneurysm and dissection: Data mining of the public version of the FDA adverse event reporting system.评估氟喹诺酮类药物相关的主动脉瘤和主动脉夹层:美国食品药品监督管理局不良事件报告系统公开版本的数据挖掘
Int J Clin Pract. 2019 May;73(5):e13331. doi: 10.1111/ijcp.13331. Epub 2019 Apr 25.
2
An evaluation of reports of ciprofloxacin, levofloxacin, and moxifloxacin-association neuropsychiatric toxicities, long-term disability, and aortic aneurysms/dissections disseminated by the Food and Drug Administration and the European Medicines Agency.评估食品药品监督管理局和欧洲药品管理局发布的关于环丙沙星、左氧氟沙星和莫西沙星与神经精神毒性、长期残疾以及主动脉瘤/夹层之间关联的报告。
Expert Opin Drug Saf. 2019 Nov;18(11):1055-1063. doi: 10.1080/14740338.2019.1665022. Epub 2019 Sep 18.
3
Fluoroquinolone-associated tendon-rupture: a summary of reports in the Food and Drug Administration's adverse event reporting system.氟喹诺酮类药物相关肌腱断裂:美国食品药品监督管理局不良事件报告系统中的报告总结
Expert Opin Drug Saf. 2015;14(11):1653-60. doi: 10.1517/14740338.2015.1085968. Epub 2015 Sep 22.
4
Oral fluoroquinolones and risk of aortic aneurysm or dissection: A nationwide population-based propensity score-matched cohort study.口服氟喹诺酮类药物与主动脉瘤或夹层的风险:一项基于全国人群的倾向评分匹配队列研究。
Pharmacotherapy. 2023 Sep;43(9):883-893. doi: 10.1002/phar.2841. Epub 2023 Jul 11.
5
Risk of aortic aneurysm and aortic dissection with the use of fluoroquinolones in Korea: a nested case-control study.韩国使用氟喹诺酮类药物导致主动脉瘤和主动脉夹层的风险:一项巢式病例对照研究。
BMC Cardiovasc Disord. 2022 Feb 13;22(1):44. doi: 10.1186/s12872-022-02488-x.
6
Risk of Aortic Dissection and Aortic Aneurysm in Patients Taking Oral Fluoroquinolone.口服氟喹诺酮类药物患者的主动脉夹层和主动脉瘤风险。
JAMA Intern Med. 2015 Nov;175(11):1839-47. doi: 10.1001/jamainternmed.2015.5389.
7
Association Between Fluoroquinolone Use and Hospitalization With Aortic Aneurysm or Aortic Dissection.氟喹诺酮类药物的使用与主动脉瘤或主动脉夹层住院之间的关联。
JAMA Cardiol. 2023 Sep 1;8(9):865-870. doi: 10.1001/jamacardio.2023.2418.
8
Assessing carbamazepine and oxcarbazepine-associated Stevens-Johnson syndrome/toxic epidermal necrolysis: Data mining the public version of the FDA adverse event reporting system.评估卡马西平和奥卡西平相关的史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症:从 FDA 不良事件报告系统公开版本中挖掘数据。
Int J Clin Pract. 2021 Aug;75(8):e14273. doi: 10.1111/ijcp.14273. Epub 2021 May 17.
9
A real-world pharmacovigilance study of axitinib: data mining of the public version of FDA adverse event reporting system.阿昔替尼的真实世界药物警戒研究:FDA 不良事件报告系统公开版本的数据挖掘。
Expert Opin Drug Saf. 2022 Apr;21(4):563-572. doi: 10.1080/14740338.2022.2016696. Epub 2021 Dec 31.
10
Fluoroquinolones and the Risk of Aortic Aneurysm or Aortic Dissection: A Systematic Review and Meta-Analysis.氟喹诺酮类药物与主动脉瘤或主动脉夹层风险:一项系统评价和荟萃分析
Cardiovasc Hematol Agents Med Chem. 2019;17(1):3-10. doi: 10.2174/1871525717666190402121958.

引用本文的文献

1
A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for Definity.一项针对Definity的FDA不良事件报告系统(FAERS)事件的真实世界药物警戒研究。
PLoS One. 2025 Aug 29;20(8):e0331444. doi: 10.1371/journal.pone.0331444. eCollection 2025.
2
Recombinant human growth hormone and brain neoplasm association: a pharmacovigilance and Mendelian randomization analysis based on US FAERS, Japanese JADER, and Canadian CVARD.重组人生长激素与脑肿瘤的关联:基于美国FAERS、日本JADER和加拿大CVARD的药物警戒与孟德尔随机化分析
Front Pharmacol. 2025 Jul 29;16:1630843. doi: 10.3389/fphar.2025.1630843. eCollection 2025.
3
Safety of lifitegrast: A real-world pharmacovigilance study based on FAERS.
lifitegrast的安全性:一项基于FAERS的真实世界药物警戒研究。
PLoS One. 2025 Apr 24;20(4):e0321307. doi: 10.1371/journal.pone.0321307. eCollection 2025.
4
Effect of FluoRoquinolones on Aortic Growth, aortic stIffness and wave refLEctionS (FRAGILES study).氟喹诺酮类药物对主动脉生长、主动脉僵硬度和波反射的影响(FRAGILES研究)
Life (Basel). 2024 Aug 9;14(8):992. doi: 10.3390/life14080992.
5
Safety of fluoroquinolones.氟喹诺酮类药物的安全性。
Rev Esp Quimioter. 2024 Apr;37(2):127-133. doi: 10.37201/req/143.2023. Epub 2023 Dec 22.
6
Aneurysm and Artery Dissection After Oral VEGFR-TKI Use in Adults With Cancer.成人癌症患者口服 VEGFR-TKI 后发生的动脉瘤和动脉夹层。
JAMA Netw Open. 2023 Nov 1;6(11):e2345977. doi: 10.1001/jamanetworkopen.2023.45977.
7
A pharmacovigilance study of etoposide in the FDA adverse event reporting system (FAERS) database, what does the real world say?在FDA不良事件报告系统(FAERS)数据库中进行的依托泊苷药物警戒研究,现实情况如何?
Front Pharmacol. 2023 Oct 26;14:1259908. doi: 10.3389/fphar.2023.1259908. eCollection 2023.
8
Safety signals of albumin-bound paclitaxel: Data mining of the Food and Drug Administration adverse event reporting system.白蛋白结合型紫杉醇的安全信号:食品药品监督管理局不良事件报告系统的数据挖掘。
Indian J Pharmacol. 2023 May-Jun;55(3):167-173. doi: 10.4103/ijp.ijp_640_22.
9
Atypical femur fracture associated with common anti-osteoporosis drugs in FDA adverse event reporting system.美国食品药品监督管理局不良事件报告系统中与常见抗骨质疏松药物相关的非典型股骨骨折。
Sci Rep. 2023 Jul 5;13(1):10892. doi: 10.1038/s41598-023-37944-x.
10
Antibiotic resistance of the bacterial spectrum of deep space head and neck infections in oral and maxillofacial surgery - a retrospective study.口腔颌面外科深部空间头颈部感染的细菌谱的抗生素耐药性-一项回顾性研究。
Clin Oral Investig. 2023 Aug;27(8):4687-4693. doi: 10.1007/s00784-023-05095-y. Epub 2023 Jun 9.